TherapeuticsMD (NASDAQ:TXMD) Trading 1.3% Higher – Here’s What Happened

TherapeuticsMD, Inc. (NASDAQ:TXMD) traded up 1.3% during trading on Thursday . The stock traded as high as $1.63 and last traded at $1.61. 20,783 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 162,892 shares. The stock had previously closed at $1.59.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of TherapeuticsMD in a research report on Monday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, TherapeuticsMD has a consensus rating of “Sell”.

TherapeuticsMD Price Performance

The stock has a 50 day moving average price of $1.33 and a 200-day moving average price of $1.22. The stock has a market capitalization of $18.63 million, a price-to-earnings ratio of -161.00 and a beta of 0.41.

TherapeuticsMD (NASDAQ:TXMD) last posted its quarterly earnings data on Wednesday, November 12th. The company reported $0.01 EPS for the quarter. The firm had revenue of $0.78 million during the quarter. TherapeuticsMD had a return on equity of 0.27% and a net margin of 10.80%.

Hedge Funds Weigh In On TherapeuticsMD

A hedge fund recently raised its stake in TherapeuticsMD stock. Citadel Advisors LLC grew its stake in TherapeuticsMD, Inc. (NASDAQ:TXMD) by 125.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 34,273 shares of the company’s stock after acquiring an additional 19,073 shares during the quarter. Citadel Advisors LLC owned about 0.30% of TherapeuticsMD worth $36,000 as of its most recent SEC filing. 30.74% of the stock is owned by hedge funds and other institutional investors.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.